Mirsaeidi et al developed a score for predicting mortality for patients with ventilator-associated pneumonia (VAP). This can help to identify patients who may benefit from more aggressive management. The authors are from the IMPACT-HAP Investigators (Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia).